The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

West Virginia University microbiologists have identified an antibody that can kill one of the most drug-resistant bacteria. Now, they want to determine whether it can be combined with other antibiotic ...

The therapeutic antibody industry has been propelled by ... the details of which are discussed in this focus issue of Nature Reviews Immunology. In their Timeline article, Alain Beck, Thierry ...

but the extent of these reviews are still uncertain. New monoclonal antibodies directed against new targets are under development, and hopefully several will emerge as alternative agents in the ...

A UK study finds detectable antibodies reduce COVID-19 infection and severity in immunosuppressed individuals, highlighting ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

Antibodies, also known as immunoglobulins (IGs), are glycoproteins produced in response to an immune reaction and exhibit high specificity for the antigens that elicit the response. An antibody ...

The results can inform a doctor if a person has an elevated level of thyroglobulin antibodies, which could indicate autoimmune diseases or cancer. This article reviews the TgAb test, what to ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

Company plans to initiate a Phase 1/b trial in relapsed/refractory, locally advanced/metastatic bladder cancer by year-end ...